Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
-
Fraser Institute News Release: B.C. health-care wait times and student test scores worsen despite marked increases in government spending
-
Falcon Oil & Gas Ltd - TSX Venture Exchange Conditional Approval & Additional Subscription
-
Cogent Biosciences Reports First Quarter 2024 Financial Results
-
Rodedawg (OTC: RWGI) Expands Tree Moguls ™ Brands into Retail Cannabis Dispensaries and Cannabis Delivery Services
-
Sales and Profitability Growth Drive Continuing Momentum in L.B. Foster First Quarter 2024 Results; Company Reaffirms 2024 Guidance
-
Erasca to Present at the Bank of America Health Care Conference
-
Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13
-
Mia Celebrates One Year of AI Education for Women Around the Globe
-
Portillo’s Inc. Announces First Quarter 2024 Financial Results
-
Aspira Women’s Health Announces Publication of Two OvaWatch Peer-Reviewed Manuscripts
-
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Irma Velazquez, CEO of Energy and Water Development Corp.
-
Daré Bioscience to Host First Quarter 2024 Financial Results and Company Update Conference Call and Webcast on May 14, 2024
-
Windtree Therapeutics Regains Compliance with Nasdaq
-
Virtuozzo Partners with MongoDB to Expand Global Availability of Database-as-a-Service
-
Pixalate Releases Ad Industry’s First MALformed And Fraudulent Bundle IDs (MALAFIDE) Risk Report for Connected TV Advertising: 46% of Bundle IDs Are Malformed and/or Fraudulent, Accounting for $150M
-
Core Molding Technologies Reports Fiscal 2024 First Quarter Results
-
Reflect Scientific Inc. Announces Second Quarter Sale of Groundbreaking Aerospace Manufacturing Solution
-
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Nuwellis, Inc. Announces First Quarter 2024 Financial Results
-
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
-
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on the Development of a mRNA-Engineered iPSC Line which Mimics Native B2M Expression, via Targeted Insertion of HLA-E at the B2M Locus
-
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
-
BioAtla to Announce First Quarter 2024 Financial Results and Provide Business Highlights on May 14, 2024
-
Speedemissions, Inc. Announces Student Winners of its Inaugural $100,000 “Project Planet Young Entrepreneur” Competition
-
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that
-
Apnimed Named 2024 Best Places to Work Company by the Boston Business Journal
-
VPN Risk Report Finds More Than Half of Organizations Experienced a VPN-related Cyberattack in the Last Year
-
ManTech Appoints Dr. Kristen Summers as Vice President and Artificial Intelligence Technical Fellow
-
Greenridge Exploration Announces 2024 Work Program for its Weyman Copper Project
-
Golden Sun Health Technology Group Limited Regains Compliance with Nasdaq Continued Listing Requirement
-
Haoxi Health Technology Limited Enters into Rebate Agreement with Clients on Advertising Placement Campaign
-
Soaring Achieves First Documented Nighttime Live Fire Exercise Autonomous Aerial Ammunition Resupply Via Tactical Drone With U.S. Army 25th Infantry Division
-
Phunware Appoints Hospitality Industry Veteran as Strategic Advisor to Propel Hospitality Sector Growth
-
CMO Council Maps Ways to Speed and Personalize Service to the 50 Million Americans Who Visit Drive-Thru Restaurants Daily
-
Whitestone REIT Board Leaders Issue Open Letter to Shareholders
-
Sagimet Announces Oral Presentation of Data from the Phase 2b FASCINATE-2 Study of Denifanstat in MASH at EASL International Liver Congress 2024
-
Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™
-
Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference
-
Oxford Lane Capital Corp. Schedules Fourth Fiscal Quarter Earnings Release and Conference Call for May 14, 2024
-
Else Nutrition Schedules First Quarter 2024 Business Update Conference Call
-
Integer to Showcase Strategic Investments to Support Customers’ Growth and Innovation at Heart Rhythm 2024
-
Talkspace Announces First Quarter 2024 Results
-
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
-
4DMT to Participate in Upcoming Investor Conference
-
Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
-
PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024
-
INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9
-
GCM Grosvenor Reports First Quarter 2024 Earnings Results
-
Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update
